February 2017 FDA Recall Cyclosporine by Amerisource Health Services
D-0490-2017 - Failed Impurities/Degradations Specifications; out of specification results for Maximum Unknown Impurities and Total Impurities

This Class II drug recall was voluntarily initiated by Amerisource Health Services on February 8, 2017 for the product Cyclosporine. The FDA reported the reason for recall as failed impurities/degradations specifications; out of specification results for maximum unknown impurities and total impurities. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-0490-2017

Reason for Recall
Failed Impurities/Degradations Specifications; out of specification results for Maximum Unknown Impurities and Total Impurities
Initiated
02-08-2017
Reported
03-08-2017
Quantity
454 cartons

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Amerisource Health Services
CycloSPORINE Capsules, USP, 100 mg, 30 count (5x6) blister cartons, Rx only, Distributed by American Health Packaging, Columbus, OH--- NDC 68084-921-25

Batch or Lot Expiration Information

Lot# Lot 154527, exp 4/30/2017